• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Curis, Inc. (CRIS)

    -NasdaqGM
    1.84 Down 0.02(1.08%) Jan 30, 4:00PM EST
    Add to Portfolio
    Prev Close:1.86
    Open:1.90
    Bid:1.80 x 1000
    Ask:N/A
    1y Target Est:5.00
    Beta:0.99
    Earnings Date:Feb 18 - Feb 23 (Est.)
    Day's Range:1.81 - 1.92
    52wk Range:1.09 - 3.40
    Volume:582,051
    Avg Vol (3m):555,564
    Market Cap:158.25M
    P/E (ttm):N/A
    EPS (ttm):-0.20
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CRIS

    Comparison

    Symbol% ChgMkt Cap
    CRISDown 1.08%158.25M
    EXELDown 5.08%365.05M
    INFIUp 1.45%752.95M
    PFEDown 1.82%196.90B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):17.06
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.22
    Quarterly EPS Est (Dec-14) :-0.07
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Curis, Inc. is engaged in the research, development, and commercialization of cancer therapeutics. It focuses on developing cancer drug candidates, including CUDC-907, an oral, small molecule drug candidate that is designed to inhibit histone deac... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback